Kura Sushi is one of the better restaurant names, and the dip looks like a good buy, in line with Trump's apparent view. The Cupertino location near Apple's headquarters always had an hour-long line, and new locations have opened around Berkeley and elsewhere. x.com  x.com 

Kura Oncology's 15% one-day jump is pure ticker confusion, making it the cleanest fade on the tape if puts are liquid. Trump's Q1 disclosure showed $1-5M in "Kura," meaning Kura Sushi USA, but retail bought Kura Oncology, an unrelated clinical-stage cancer biotech now at a $917M market cap. The intended buy may even have been Fujikura, a Japanese fiber-optic supplier. Options activity is extreme for a thinly traded stock, with a 0.007 put/call ratio and no fundamental anchor. x.com 

Kura Sushi is leveraging up in the restaurant sector and will be bankrupt in six months. Per Bloomberg, the conveyor-belt sushi chain targets 20% annual US store growth, betting it can build market share before a wave of competitors arrives. x.com 

The Nasdaq 100 has a good chance of topping before year-end this year, breaking a streak that has held every year since 2022, because semiconductors are at a major top. Even after two 10% corrections in the index since June, everyone still wants to buy tech. x.com  x.com  x.com 

The bounce in semiconductors, including AMD, Micron and Intel, looks like a retail trap and exit liquidity rather than a durable move. The AI and semiconductor bull cycle is still in play, but a redistribution back down to weekly fair value looks next, after which big money should buy again. This is not a call to short. x.com  x.com